RedHill Biopharma vs 60 Degrees Pharmaceuticals
RDHL and SXTP side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How RDHL and SXTP compare
60 Degrees Pharmaceuticals grew revenue faster over the last twelve months (73.2% versus −96.4% for RedHill Biopharma).
60 Degrees Pharmaceuticals scores higher on the StockData Score (8 against 0 for RedHill Biopharma), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | RDHL | SXTP |
|---|---|---|
| Size and price | ||
| Market cap | – | $1.8M |
| Share price | $0.375 | $0.518 |
| Change, 1 year | −65.0% | −89.5% |
| Change, 5 years | −100.0% | – |
| Beta (5Y) | 1.71 | 2.09 |
| Employees | 13 | 3 |
| StockData Score | ||
| Total score | 0 | 8 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 0 | 2 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 1.6× |
| P/B | – | 0.7× |
| FCF yield | – | −488% |
| Fair value | – | $1.29 |
| Margin of safety | – | 59.7% |
| Growth | ||
| Revenue growth (TTM) | −96.4% | 73.2% (better) |
| Revenue growth, 5Y average | −66.2% | – |
| Profitability | ||
| Gross margin | – | 19.4% |
| Operating margin | −2777% | −775% (better) |
| Net margin | – | −730% |
| FCF margin | −3376% | −801% (better) |
| Return on equity | – | −322% |
| Return on invested capital | – | −659% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −5.5× (better) | −1134.8× |
| Current ratio | 0.34 | 2.32 (better) |
| Altman Z-score | – | −22.23 |
| Piotroski F-score | – | 2 |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 0.00% | 21.5% |
| Held by insiders | 4.4% | 21.0% |
| Insider net buying, 12 months | −$1.4K | $30.1K (better) |
Go deeper
- RDHL stock overview
- RDHL income statement
- RDHL valuation and score
- SXTP stock overview
- SXTP income statement
- SXTP valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.